Imaging medicine to help find lung cancer during surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a special imaging drug (IRDye800CW-nimotuzumab) that may help surgeons better see lung cancer tissue during planned lung surgery. Phase 1/2 looks mainly at safety and how well the imaging works to guide the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage I or stage II non-small cell lung cancer that can be removed by surgery
- You are 18 to 80 years old and can sign informed consent
- You are healthy enough for lung surgery based on the surgeon’s assessment
- You have not had cancer before, and you have not had chemotherapy or other treatment before surgery
- Your blood counts are high enough (hemoglobin, white blood cells, and platelets) and your kidney function is acceptable
- You should not have serious recent heart/stroke issues or unstable breathing conditions like lung scarring (pulmonary fibrosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dye called abenacianine (VGT-309) that may help surgeons see cancer more clearly during lung surgery. It looks at whether the dye is safe and effective for identifying cancer in people having surgery to remove a lung lesion or mass.
This trial tests a special imaging tool that helps surgeons see lung cancer tissue during surgery, so they can remove it more completely. It may help people having surgery to remove a lung tumor.
This trial tests a special dye drug (panitumumab-IRDye800) that may help surgeons better see lung cancer areas while operating. If it works, it could improve how well cancer tissue is found and removed during planned lung surgery.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.